Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuki Niwa is active.

Publication


Featured researches published by Kazuki Niwa.


Journal of Biomaterials Science-polymer Edition | 2004

Sulfation of silk sericin and anticoagulant activity of sulfated sericin

Yasushi Tamada; Masanari Sano; Kazuki Niwa; Toshio Imai; Gen Yoshino

—Silk sericin extracted from a cocoon was sulfated by chlorosulfonic acid. Sulfation of sericin was confirmed by FT-IR and the reaction efficiency was calculated as 44.9%. 1H-NMR suggested that sulfation mainly occurred at serine residues in the sericin molecule. The sulfated sericin was separated in three fractions by gel-filtration chromatography using Sephacryl S-200. The sulfate group content and amino-acid composition of each fraction were almost identical, while the anticoagulant activity differed for each fraction of sulfated sericin. Higher anticoagulant activity was observed for the higher-molecular-mass fraction. The anticoagulant activity of sulfated sericin was estimated at 1/10 to 1/20 of heparin.


Journal of Biological Chemistry | 1997

Fibroblasts Spread on Immobilized Fibrin Monomer by Mobilizing a β1-class Integrin, Together with a Vitronectin Receptor αvβ3 on Their Surface

Shinji Asakura; Kazuki Niwa; Takako Tomozawa; Yong Ming Jin; Seiji Madoiwa; Yoichi Sakata; Takao Sakai; Hiroshi Funayama; Gilbu Soe; Fran Forgerty; Hajime Hirata; Michio Matsuda

Human and murine fibroblasts were found to spread far more avidly on fibrin monomer monolayers than on immobilized fibrinogen, indicating that removal of fibrinopeptides by thrombin is a prerequisite for the fibrin-mediated augmentation of cell spreading. In fact, cell spreading was not efficiently augmented on monolayers of a thrombin-treated dysfibrinogen lacking the release of fibrinopeptide A due to an Aα Arg-16 → Cys substitution. Since a synthetic Arg-Gly-Asp (RGD)-containing peptide inhibited the fibrin-mediated cell spreading, subsequent dissociation of the carboxyl-terminal globular domain of the Aα-chains appears to render the RGD segments accessible to the cell-surface integrins. In support of this, fibrin-augmented cell spreading was inhibited by an antibody recognizing a 12-kDa peptide segment with γ Met-89 at its amino terminus, which is located in close association with the RGD segment at Aα 95-97 in the helical coiled-coil interdomainal connector. The fibrin-mediated augmentation of cell spreading was inhibited not only by an antibody against human vitronectin receptor (LM 609) but also by an antibody against the β1 subunit of integrin (mAb13), suggesting that the β1-class integrin together with a vitronectin receptor, αvβ3, is mobilized onto the surface of fibroblasts upon contact with the fibrin monomer monolayer.


Journal of Biomaterials Science-polymer Edition | 2009

Sulfated Sericin is a Novel Anticoagulant Influencing the Blood Coagulation Cascade

Masanari Sano; Yasushi Tamada; Kazuki Niwa; Toshisuke Morita; Gen Yoshino

Sulfated sericins influence on factors in the blood coagulation cascade was investigated to elucidate its anticoagulant mechanism. Prolongation of the prothrombin time (PT) and activated partial thromboplastin time (APTT) were observed in the presence of sulfated sericin. Fluorogenic peptide substrates on thrombin (factor IIa) and factor Xa were used to study the influence of sulfate sericin on their respective activities. Sulfated sericin inhibited neither thrombin nor factor Xa in the presence of antithrombin III (AT III). Gel electrophoresis was used to examine fibrinogen–fibrin conversion by thrombin in the presence of sulfated sericin. FPA and FPB release from fibrinogen by thrombin proceeded in the presence of sulfated sericin. The behavior of polymerization of fibrin monomer (FM) was affected by the presence of sulfated sericin. No initial lag time in the polymerization process was observed by addition of sulfated sericin to FM. This result means that sulfated sericin will interfere in the build-up of normal double-strand fibrils of FM during formation of fibrin fiber. Scanning electron microscopy (SEM) observations supported this inference. The anticoagulant mechanism of sulfated sericin is inferred to interfere with the initial polymerization process of FM.


Key Engineering Materials | 2006

Immediate Mechanism of the Osteoconductivity of the Polarized Hydroxyapatite

Miho Nakamura; Yasutaka Sekijima; Satoshi Nakamura; Kazuki Niwa; Takayuki Kobayashi; Kimihiro Yamashita

We investigated the immediate response in the vicinity of the implanted polarized hydroxyapatite (HA). One of the important immediate events was found to be the fibrin adsorption on the implanted HA. The activation of the fibrin adsorption on the polarized HA was confirmed by the observation by SEM observation and immunohistochemical detection. After the implantation, the coagulation cascade induced the wound healing. The adsorbed fibrin was formed network structure and worked for later cell responses as the scaffolds. The acceleration of fibrin scaffolds formation in the vicinity of the implanted polarized HA contributed to the stimulation and activation of plate ets and osseous cells. The platelets were activated from the results of the signal transduction and cytoskeleton changes and released growth factors. The growth factors released from platelets led to bone regeneration by stimulating migration and proliferation of the osseous cells. In the vicinity of the implanted HA samples, the coagulation cascade reaction to repair wound healing led to the new bone formation by mediation of the platelets and osseous cells. The mechanism of osteoconduction at earlier stage had close relationships to the electrostatic properties of the implant.


Journal of Biomedical Materials Research Part A | 2006

Role of blood coagulation components as intermediators of high osteoconductivity of electrically polarized hydroxyapatite.

Miho Nakamura; Yasutaka Sekijima; Satoshi Nakamura; Takayuki Kobayashi; Kazuki Niwa; Kimihiro Yamashita


Thrombosis and Haemostasis | 1999

Structure and Function of Fibrinogen: Insights from Dysfibrinogens

Michio Matsuda; Teruko Sugo; Nobuhiko Yoshida; Shigeharu Terukina; Kensuke Yamazumi; Kazuki Niwa; Hisato Maekawa


Journal of Biomedical Materials Research Part B | 2007

Interaction of a blood coagulation factor on electrically polarized hydroxyapatite surfaces.

Miho Nakamura; Kazuki Niwa; Satoshi Nakamura; Yasutaka Sekijima; Kimihiro Yamashita


Blood | 2000

End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure

Teruko Sugo; Chizuko Nakamikawa; Nobuhiko Yoshida; Kazuki Niwa; Masazumi Sameshima; Jun Mimuro; John W. Weisel; Akira Nagita; Michio Matsuda


Blood | 1996

A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I

Kazuki Niwa; Takebe M; Teruko Sugo; Yoichi Kawata; Jun Mimuro; Shinji Asakura; Youichi Sakata; Mizushima J; Maeda A; Endo H; Michio Matsuda


Blood | 2004

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of γ ALa327thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism

Akiei Hamano; Jun Mimuro; Motonori Aoshima; Takeyoshi Itoh; Noboru Kitamura; Susumu Nishinarita; Katsuhiro Takano; Akira Ishiwata; Yuji Kashiwakura; Kazuki Niwa; Tomoko Ono; Seiji Madoiwa; Teruko Sugo; Michio Matsuda; Yoichi Sakata

Collaboration


Dive into the Kazuki Niwa's collaboration.

Top Co-Authors

Avatar

Michio Matsuda

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Mimuro

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Kimihiro Yamashita

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Miho Nakamura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Nakamura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Seiji Madoiwa

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Yasutaka Sekijima

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yoichi Sakata

Jichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Shinji Asakura

University of Wisconsin-Madison

View shared research outputs
Researchain Logo
Decentralizing Knowledge